# A Study To Taste Three New Types Of Crizotinib Formulation In Comparison Of An Oral Solution And To Measure The Amount Of Crizotinib In The Body After These Formulations Are Orally Given, Relative To Capsule Formulation

> **NCT02006277** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 21 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Crizotinib prototype microsphere 0.529 mg/mg
- **DRUG:** crizotinib prototype microsphere 0.470 mg/mg
- **DRUG:** crizotinib prototype microsphere 0.420 mg/mg
- **DRUG:** crizotinib oral solution
- **DRUG:** crizotinib prototype microsphere 0.529 mg/mg
- **DRUG:** crizotinib prototype microsphere 0.470 mg/mg
- **DRUG:** crizotinib prototype microsphere 0.420 mg/mg
- **DRUG:** crizotinib capsule
- **DRUG:** crizotinib oral solution

## Key facts

- **NCT ID:** NCT02006277
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2014-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02006277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02006277, "A Study To Taste Three New Types Of Crizotinib Formulation In Comparison Of An Oral Solution And To Measure The Amount Of Crizotinib In The Body After These Formulations Are Orally Given, Relative To Capsule Formulation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02006277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*